Publications
171
Citations
3,822
Est. group size
~2
Recurring co-author estimate
Active years
22
Publishing since 2005
Stacy P. Ardoin studies childhood-onset systemic lupus erythematosus (a pediatric autoimmune disease affecting multiple organs), with particular focus on cardiovascular risk and atherosclerosis, biomarker and immune-signature discovery, kidney (lupus nephritis) treatment trials, and emerging therapies like CAR T cells. The work combines clinical trials, biomarker/metabolomic studies, and multicenter registry research aimed at improving outcomes for young people with lupus and related pediatric rheumatic conditions.
Publication output has been relatively steady over the last decade, fluctuating between roughly 8 and 17 papers per year without a clear long-term upward or downward trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approach
Annals of the Rheumatic Diseases · 2026
- PT6:03 Autoantibody signatures predict atherosclerosis progression and statin response in juvenile-onset systemic lupus erythematosus
2026
- Autoantibodies Predictive of Atherosclerosis Progression and Statin Response in Juvenile-Onset SLE: A Biomarker Discovery Study
medRxiv · 2026
- CAR T cell therapy for children with rheumatic disease: the time is now
Nature Reviews Rheumatology · 2025
- Multicenter randomized controlled trial of cognitive-behavioral, exercise-based, and combined interventions for juvenile fibromyalgia
Pain · 2025
- 47: Progression pattern of skin-limited pediatric-onset discoid lupus erythematosus to systemic lupus erythematosus
Journal of Investigative Dermatology · 2025
- Systemic Lupus Erythematosus in Adolescence and Young Adulthood
In clinical practice · 2025
- PERFORMANCE OF VALIDATED CARDIOVASCULAR RISK SCORES IN A GLOBAL (UK/US) COHORT OF YOUNG PEOPLE WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS STRATIFIED BASED ON CROSS-VALIDATED METABOLOMIC SIGNATURES
The Journal of Rheumatology · 2025
- Characteristics Associated With <scp>EuroLupus</scp> Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus Nephritis
ACR Open Rheumatology · 2025
- Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus Nephritis
UNC Libraries · 2025
- CAR T cell therapy for refractory pediatric systemic lupus erythematosus: a new era of hope?
Pediatric Rheumatology · 2024
- Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research
Annals of the Rheumatic Diseases · 2024
- Cardiovascular risk in young people with childhood onset systemic lupus erythematosus
The Lancet Rheumatology · 2024
- Efficacy and Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis-A Double-Blind Placebo Controlled Clinical Trial (The Pediatric Lupus Nephritis Mycophenolate Mofetil Study).
PubMed · 2024
- Investigation of the performance of validated cardiovascular risk scores in a global (UK/US) cohort of young people with childhood-onset systemic lupus erythematosus
Lupus Science & Medicine · 2024
- Pediatric Rheumatology×17
- Annals of the Rheumatic Diseases×9
- Arthritis Care & Research×8
- The Journal of Rheumatology×6
- Lupus×6
- Kyla Driest
Medicine · The Ohio State University
- Jessica Greco
Medicine · The Ohio State University
- Haichang Li
Medicine · The Ohio State University
- B.H. Rovin
Medicine · The Ohio State University
- Huijuan Song
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile